MAPK8 and Cognitive impairment: This study found that GBH could reduce lipid peroxidation and ERK/JNK activation in RSL3-induced HT22 cells in vitro and undermine cognitive impairment by Aβ25–35 in vivo, providing a potential strategy for treating ferroptosis-related neurodegenerative diseases.